|
|
|
|
The immune system has two mechanisms of specific or adaptive
immunity, the antibody response and the T-cell response. The T-cell
response includes a class of T-cells called cytotoxic T-cells (CD8
cells) that are able to recognize infected cells when antigens are
presented on their surface in association with MHC class I
molecules.
The specific immunity conferred by these two mechanisms allows for an individual to develop a prolonged resistance to specific pathogens following an initial exposure. The establishment and use of vaccines is based on this principle.
These scientists sought to develop and study a vaccine against the Human Immunodeficiency Virus (HIV). Rhesus monkeys were used in this experiment, however they are not susceptible to HIV. Therefore the use of a hybrid between Simian Immunodeficiency Virus (SIV) and HIV called SHIV was required. These monkeys were given the vaccine and later exposed to SHIV. All monkeys developed an SHIV infection but those that were vaccinated experienced an improved ability to control chronic infection. However, in one monkey vaccine eventually failed leading to viral breakthrough and the decline of the subject. This paper seeks to understand the reasons and mechanism for this failure.
This module will guide you as we follow the path of the experimenters as they seek to understand the mechanisms behind the virus's interactions with the body. Click on the next to be taken step by step through the experiment or use the nav bar on each page to explore yourself.
NEXT
|
|
|
|
|
|
|
Based on the following paper:
Barouch, D.H., Kuntsman, J., Kuroda, M.J., Schmitz, J.E., Santra, S., Peyeri, F.W., Krivulka, G.R., Beaurdry, K., Lifton, M.A., Gorgone, D.A., Monteffiori, D.C., Lewis, M.G., Wolinsky, S.M., Letvin, N.L. 2002. Eventual AIDS Vaccine Failure in a Rhesus Monkey by Viral Escape from Cytoxic T Lymphocytes. Nature. Vol. 415. pg. 335
Website designed and created by A.D and F. Stebbins